Roles of nitric oxide in tumor growth.
- Publication Type:
- Journal Article
- Citation:
- Proc Natl Acad Sci U S A, 1995, 92 (10), pp. 4392 - 4396
- Issue Date:
- 1995-05-09
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
 | 2009002921OK.pdf | 1.48 MB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
A subclone of the human colon adenocarcinoma cell line DLD-1, which grew reproducibly as subcutaneous tumors in nude mice, was isolated. Such cells, when engineered to generate nitric oxide (NO) continuously, grew more slowly in vitro than the wild-type parental cells. This growth retardation was reversed by the addition of N-iminoethyl-L-ornithine. In nude mice, however, the tumors from these cells grew faster than those derived from wild-type cells and were markedly more vascularized, suggesting that NO may act as part of a signaling cascade for neovascularization. Recent observations that the generation of NO in human breast and gynecological cancers correlates positively with tumor grade are consistent with this hypothesis. We suggest that NO may have a dual pro- and antitumor action, depending on the local concentration of the molecule.
Please use this identifier to cite or link to this item: